Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENSCRIPT BIO

15.860
-0.410-2.52%
Volume:4.00M
Turnover:63.93M
Market Cap:34.65B
PE:1.46
High:16.230
Open:16.060
Low:15.800
Close:16.270
52wk High:19.400
52wk Low:8.880
Shares:2.19B
HK Float Shares:2.19B
Volume Ratio:0.48
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(LYR):10.844
ROE:-1.94%
ROA:2.56%
PB:1.01
PE(LYR):1.46
PS:5.39

Loading ...

GENSCRIPT BIO (01548): CARVYKTI® Generates Net Trade Sales of Approximately $524 Million for Quarter Ended September 30, 2025

Stock News
·
Oct 14

Legend Biotech Announces FDA Approval of CARVYKTI® Label Update to Include Overall Survival Data and New Safety Warnings

Reuters
·
Oct 14

Legend Biotech Reports Preliminary CARVYKTI® Net Trade Sales of $524 Million for Q3 2025

Reuters
·
Oct 14

GENSCRIPT BIO (01548): Subsidiary Receives New Payment Under License Agreement with LM Pharma

Stock News
·
Oct 14

GenScript Biotech announces payment received under license agreement with LaNova Medicines

Reuters
·
Oct 14

Is Genscript Biotech Corporation (HKG:1548) Trading At A 44% Discount?

Simply Wall St.
·
Oct 11

US FDA adds boxed warning to J&J, Legend Biotech's cancer therapy

Reuters
·
Oct 11

Legend Biotech Signs Component and Product Supply Agreement with Janssen Pharmaceuticals for Cilta cel Manufacturing

Reuters
·
Oct 08

GENSCRIPT BIO (01548) Awards 775,000 Shares Under 2019 Restricted Share Unit Plan

Stock News
·
Sep 21

Genscript Biotech First Half 2025 Earnings: US$0.012 loss per share (vs US$0.046 loss in 1H 2024)

Simply Wall St.
·
Sep 14

COO Shao Weihui Reduces Holdings in GENSCRIPT BIO (01548) by Approximately 115,500 Shares at HK$17.35 Per Share

Stock News
·
Sep 08

MEDIA-Legend Biotech is said to explore second listing outside of US - Bloomberg News

Reuters
·
Sep 05

Legend Biotech Corporation to Participate in Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 26

U.S. RESEARCH ROUNDUP-Amgen, Figma, Nordson

Reuters
·
Aug 25

Goldman Sachs Cuts GENSCRIPT BIO (01548) Target Price to HK$26.25, Lowers Profit Forecasts

Stock News
·
Aug 21

CICC: Maintains "Outperform" Rating for GENSCRIPT BIO (01548), Raises Target Price to HK$21.50

Stock News
·
Aug 18

Press Release: GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation

Dow Jones
·
Aug 17

GENSCRIPT BIO (01548) Reports Interim Results with Loss Attributable to Owners of $25.46 Million, Narrowing 85.46% Year-over-Year

Stock News
·
Aug 17

Genscript Biotech Corp H1 Adjusted Net Income USD 178 Million

THOMSON REUTERS
·
Aug 17

Genscript Biotech Corp H1 Gross Profit USD 320.6 Million

THOMSON REUTERS
·
Aug 17